To hear about similar clinical trials, please enter your email below
Trial Title:
A Culturally Specific End-of-life Communication Skills Training
NCT ID:
NCT05888480
Condition:
End-Of-Life
Conditions: Official terms:
Death
Conditions: Keywords:
Communication
Nurse
Terminally ill
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Sequential Assignment
Intervention model description:
The IG will receive the end-of-life CST between the two measurement points, and the CG
will be a waitlist group and receive the training after the end of data collection.
Primary purpose:
Other
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
The end-of-life communication skills training
Description:
Training methods include lectures, video demonstrations, and simulation in small groups
(4-5 trainees per group with multidisciplinary roles). Written and audiovisual learning
materials will be offered. Each session will be 150 minutes, including lectures and video
demonstration (90 min/session) and simulation and feedback (60 min/session). One session
will be conducted in two weeks. Totally there will be four sessions completed in 8 weeks.
Arm group label:
Intervention group (IG)
Intervention type:
Other
Intervention name:
Routine training activity
Description:
Routine training activities arranged by relevant departments in hospitals
Arm group label:
Control group (CG)
Summary:
The goal of this clinical trial is to evaluate the effectiveness of culturally specific
end-of-life communication skills training (CST) among Chinese oncology nurses.
The main question it aims to answer is: What is the effectiveness of culturally specific
end-of-life CST among Chinese oncology nurses? Participants will receive an 8-week
communication skills training. Researchers will compare the intervention group and the
wait-list group to see if skills, self-efficacy, and outcome expectancy beliefs will be
improved.
Detailed description:
Objectives: The study aims to evaluate the effectiveness of culturally specific
end-of-life CST among Chinese oncology nurses.
Design and participants: It is designed as a single-blind, pre-post randomized controlled
trial (RCT). Registered nurses who work with advanced cancer patients in hospital
settings will be recruited. The participants will be randomly assigned to either the
intervention group (IG) or the control group (CG). The IG will receive the end-of-life
CST between the two measurement points, and the CG will be a waitlist group and receive
the training after the end of data collection.
Data analysis: Demographic information about the participants will be summarised in
descriptive statistics. Independent t-tests and chi-square tests are used to investigate
the comparability of groups in terms of the demographics generated by randomization. The
primary and secondary outcome variables will be examined using covariate-adjusted linear
mixed models. This approach enables the consideration of missing data. For non-repeated
continuous measurements, ordinary linear regression and logistic models will be adopted.
The intention-to-treat (ITT) analysis and post hoc analyses of contaminated data will be
performed.
Expected results: Nurses' skills, self-efficacy, and outcome expectancy beliefs will
improve after the CST.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Registered nurses who work with advanced cancer patients in hospital settings
- Consent to participate in the study
Exclusion Criteria:
- Nurses working temporarily in the two hospitals as scholars or trainees from other
hospitals
- Specialized nurses in palliative care
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Zhejiang Cancer Hospital
Address:
City:
Hangzhou
Zip:
310000
Country:
China
Status:
Recruiting
Contact:
Last name:
Weilin Chen, Master
Phone:
86-15715792337
Email:
wei-lin.chen@connect.polyu.hk
Start date:
September 1, 2023
Completion date:
December 2024
Lead sponsor:
Agency:
The Hong Kong Polytechnic University
Agency class:
Other
Source:
The Hong Kong Polytechnic University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05888480
